Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
M.D. Anderson Cancer Center
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Instituto do Cancer do Estado de São Paulo
Cybrexa Therapeutics
Shanghai PerHum Therapeutics Co., Ltd.
Adaptimmune